Keywords: sales, decline, hits, santen, results, japanese, ophthalmic
US sales decline hits Santen results
Article | 22 November 2004
Japanese ophthalmic drug specialist Santen has reported that first-half- fiscal 2005 (April-September) consolidated revenue fell 2.3% year-on-year to 45.1 billion yen ($428.5 million) but ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
